Abstract | BACKGROUND: METHODS: RESULTS: CONCLUSIONS:
|
Authors | Yoshikazu Nonaka, Atsushi Nanashima, Takashi Nonaka, Masataka Uehara, Hajime Isomoto, Takafumi Abo, Takeshi Nagayasu |
Journal | The Journal of surgical research
(J Surg Res)
Vol. 181
Issue 2
Pg. 234-41
(May 2013)
ISSN: 1095-8673 [Electronic] United States |
PMID | 22835954
(Publication Type: Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2013 Elsevier Inc. All rights reserved. |
Chemical References |
- Antineoplastic Agents
- Biomarkers, Tumor
- Organoplatinum Compounds
- Photosensitizing Agents
- Porphyrins
- Proliferating Cell Nuclear Antigen
- Vascular Endothelial Growth Factor A
- vascular endothelial growth factor A, mouse
- Oxaliplatin
- Deoxycytidine
- Talaporfin
- Cisplatin
- Fluorouracil
- Gemcitabine
|
Topics |
- Animals
- Antineoplastic Agents
(administration & dosage)
- Antineoplastic Combined Chemotherapy Protocols
(pharmacology, therapeutic use)
- Apoptosis
(drug effects)
- Bile Duct Neoplasms
(drug therapy, metabolism)
- Biomarkers, Tumor
(metabolism)
- Cell Line, Tumor
- Cell Survival
(drug effects)
- Cisplatin
(administration & dosage)
- Deoxycytidine
(administration & dosage, analogs & derivatives)
- Drug Synergism
- Fluorouracil
(administration & dosage)
- Humans
- Immunohistochemistry
- In Situ Nick-End Labeling
- Male
- Mice
- Mice, Inbred BALB C
- Organoplatinum Compounds
(administration & dosage)
- Oxaliplatin
- Photochemotherapy
- Photosensitizing Agents
(pharmacology, therapeutic use)
- Porphyrins
(pharmacology, therapeutic use)
- Proliferating Cell Nuclear Antigen
(metabolism)
- Treatment Outcome
- Vascular Endothelial Growth Factor A
(metabolism)
- Gemcitabine
|